|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cancer-Related Problem/Condition | |||||
| 2 | Interventions listed in this trial | ||||
| glucarpidase | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Methotrexate | |||||
| 4 | More general drug interventions related to this trial | ||||
| Abortifacient Agents | |||||
| Abortifacient Agents, Nonsteroidal | |||||
| Antimetabolites | |||||
| Antimetabolites, Antineoplastic | |||||
| Antineoplastic Agents | |||||
| Antirheumatic Agents | |||||
| Dermatologic Agents | |||||
| Enzyme Inhibitors | |||||
| Folic Acid Antagonists | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Nucleic Acid Synthesis Inhibitors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Reproductive Control Agents | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| NCI - Center for Cancer Research-Medical Oncology | |||||
| National Cancer Institute (NCI) | |||||
| Children's Oncology Group | |||||